Sol-Gel Technologies (SLGL) Interest Coverage Ratio (2018 - 2026)
Sol-Gel Technologies (SLGL) posted quarterly Interest Coverage Ratio of 0.06 for Q4 2025, up 52.4% year-over-year from 0.04 in Q4 2024, and down 100.2% quarter-over-quarter from 29.79 in Q2 2025.
Powered by 
Analysis
Sol-Gel Technologies (SLGL) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Interest Coverage Ratio for 9 consecutive years, with 0.06 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 52.4% year-over-year to 0.06; the TTM figure through Mar 2026 stood at 14.29 (up 21.01% YoY), while the FY2025 annual figure was 0.13, up 46.6% from the prior year.
- Interest Coverage Ratio slipped to 0.06 in Q4 2025 per SLGL's latest filing, from 29.79 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 34.21 in Q4 2021 and bottomed at 0.14 in Q4 2022.
- Historically, Interest Coverage Ratio has averaged 9.81 across 5 years, with a median of 0.06 in 2025.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio tumbled 100.41% — and 2025, when it surged 485.12%.
- Sol-Gel Technologies' Interest Coverage Ratio stood at 34.21 in 2021, then plunged by 100.41% to 0.14 in 2022, then gained by 18.71% to 0.11 in 2023, then dropped by 8.54% to 0.12 in 2024, then jumped by 52.4% to 0.06 in 2025.
- Business Quant data shows SLGL's Interest Coverage Ratio at 0.06 in Q4 2025, 29.79 in Q2 2025, and 0.12 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Sol-Gel Technologies | 194.01 Mn | 146.08 Mn | - | -8.65 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.65 |
| Jun 30, 2025 | 29.55 |
| Jun 30, 2024 | 4.61 |
| Jun 30, 2023 | -11.72 |
| Jun 30, 2022 | 1.41 |
| Jun 30, 2021 | 893.56 |
| Jun 30, 2020 | 15.70 |
| Jun 30, 2019 | 14.72 |
| Jun 30, 2018 | 19.22 |